JM
Jose Mesa
Partner at Columbus Venture Partners
JM
Jose Mesa
Partner at Columbus Venture Partners
Barcelona, Catalonia
Overview
Work Experience
Board Observer
2024 - Current
Board Director
2023
Board Director
2020 - 2022
Developing personalized adjuvant treatment strategies for early-stage breast cancer.
Board Director
2020 - 2022
Discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.
Board Director
2020 - 2022
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
Board Director
2020 - 2022
Developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases
Partner
2019 - 2022
Life sciences venture capital firm
BoD Observer
2019 - 2021
Development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.
Board Director
2018 - 2019
Development of novel treatments for severe, orphan diseases of the central nervous system (CNS)